At Davos, Pfizer CEO explained Pfizer’s new technology that is “ingestible pills”with a tiny chip that send a wireless signal to relevant authorities when the pharmaceutical has been digested.
Pfizer CEO Albert Bourla impressed the audience at the World Economic Forum in Davos this week with thoughts of ingestible computer chips that notify authorities when a medicine has been digested. Probably, he may have forgotten he was on camera.
“It is a, basically biological chip that is in the tablet. And once we take the tablet and dissolves into the stomach, sends a signal that you took the table. So imagine the applications of that – the compliance. The insurance companies know that the medicines patients should take, they take them.
Pfizer’s defenders joined in, suggesting that Bourla’s futuristic pitch could be used in “specific” conditions such as “schizophrenia and cancers” to ensure compliance.